Get the Stockscreener App
6.95
0.57%
-0.04
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.95, with a volume of 1.39M.
It is down -0.57% in the last 24 hours and up +9.45% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.99
Open:
$6.95
24h Volume:
1.39M
Relative Volume:
0.57
Market Cap:
$2.58B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-14.48
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-3.20%
1M Performance:
+9.45%
6M Performance:
+4.35%
1Y Performance:
-13.77%
1-Day Range:
$6.87
$7.02
1-Week Range:
$6.87
$7.25
52-Week Range:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.95 | 2.59B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Japan Dermatology Devices Market is Driven by Skin Health - openPR.com
Bausch Health Signs Multiple Material Agreements - TradingView — Track All Markets
Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst - MarketBeat
What is Zacks Research's Estimate for TSE:BHC Q4 Earnings? - MarketBeat
Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt ExchangeHas The Bull Case Changed? - Yahoo Finance
Bausch Health announces completion of $1.6 billion debt exchange offer By Investing.com - Investing.com Nigeria
Bausch Health announces completion of $1.6 billion debt exchange offer - Investing.com
Bausch Health Announces Final Results and Expiration of Exchange Offers - ACCESS Newswire
Bausch Health Companies Inc Announces Final Results of Exchange Offers - TradingView — Track All Markets
Bausch Health Cos (NYSE:BHC) Trading Up 4.9%Time to Buy? - MarketBeat
Beauty Devices Markets, Competition and Regional Analysis - GlobeNewswire
Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO and More - Yahoo Finance
Bausch Health’s Large 2032 Debt Exchange Might Change The Case For Investing In Bausch Health (BHC) - simplywall.st
Is Bausch Health Companies Inc. (BVF) stock dividend growth reliableBear Alert & Daily Profit Maximizing Trade Tips - ulpravda.ru
Bausch Health (NYSE:BHC) Valuation Check After Strong Early Uptake of New 2032 Note Exchange Offer - Sahm
Is Bausch Health a Contrarian Opportunity After Its Recent Price Rebound and DCF Valuation Gap - Sahm
Why Bausch Health Companies Inc. stock is in analyst buy zone2025 Major Catalysts & Intraday High Probability Setup Alerts - DonanımHaber
How Bausch Health Companies Inc. stock performs in rising dollar environmentWeekly Stock Recap & Daily Entry Point Trade Alerts - Улправда
How Bausch Health Companies Inc. stock expands through international marketsJuly 2025 Pullbacks & Low Risk Investment Opportunities - DonanımHaber
Bausch + Lomb appoints two new directors to board effective January By Investing.com - Investing.com Nigeria
Bausch + Lomb appoints two new directors to board effective January - Investing.com
Bausch Health Companies (TSE:BHC) Raised to "Hold" at Raymond James Financial - MarketBeat
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Bausch Health Cos (NYSE:BHC) Raised to Hold at Raymond James Financial - MarketBeat
Icahn Money Manager Sues His Bosses and Bausch + Lomb Over Anti-White Bias - Bloomberg.com
Laser Therapy Devices Market Is Going to Boom |• Abbott • Bausch Health Companies - openPR.com
Nomura Holdings Inc. Sells 1,900,000 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
Retail Trends: Why Bausch Health Companies Inc stock is in analyst buy zoneJuly 2025 Weekly Recap & Stepwise Trade Execution Plans - moha.gov.vn
Bausch + Lomb allocates $2.8 billion to refinance outstanding loans By Investing.com - Investing.com Nigeria
Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt - MSN
Bausch Health Companies Inc Refinances Term B Loans - TradingView — Track All Markets
Bausch + Lomb allocates $2.8 billion to refinance outstanding loans - Investing.com
Bausch Health (NYSE: BHC) to refinance $2.80B Bausch + Lomb term loans with lower margins - Stock Titan
Maple Rock Capital Partners Inc. Has $52.01 Million Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health Cos Inc. $BHC Stock Holdings Lifted by Paulson & CO. Inc. - MarketBeat
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake - AOL.com
Stock Recap: How Bausch Health Companies Inc stock benefits from global expansionJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - moha.gov.vn
Barclays Initiates Coverage on Bausch Health Cos (NYSE:BHC) - MarketBeat
Bausch Health Companies (TSE:BHC) Upgraded at Barclays - MarketBeat
Bausch Health Cos Inc. $BHC Holdings Reduced by Arrowstreet Capital Limited Partnership - MarketBeat
Barclays Initiates Coverage of Bausch Health Companies (BHC) with Equal-Weight Recommendation - Nasdaq
BHC: Barclays Initiates Coverage with Equal-Weight Rating | BHC Stock News - GuruFocus
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Bausch Health Companies Inc Announces Early Exchange Offer Results - TradingView — Track All Markets
Bausch Health (NYSE:BHC) expects $1.6 billion of new 2032 notes in senior debt exchange - Stock Titan
Bausch Health Announces Early Exchange Offer Results for Exchange Offers - Yahoo Finance
Why Bausch Health (BHC) Is Up 9.1% After John Paulson Deepens His Stake – And What's Next - Sahm
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Why Investors Shouldn't Be Surprised By Bausch Health Companies Inc.'s (NYSE:BHC) Low P/S - 富途牛牛
Bausch Health ticks higher following large director stock purchase - MSN
Is Bausch Health Companies Inc. (BVF) stock a buy before earnings resultsOptions Play & Free Community Supported Trade Ideas - Newser
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.30%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):